Literature DB >> 32367313

Construction of hybrid polycyclic quinolinobenzo[a]phenazinone architectures using solid-state melt reaction (SSMR).

Manickam Bakthadoss1, Varathan Vinayagam2.   

Abstract

An efficient and versatile protocol for the synthesis of hybrid polycyclic quinolinobenzo[a]phenazinones has been developed under SSMR condition via intramolecular domino Knoevenagel-hetero-Diels-Alder reaction involving the generation of two new six membered fused rings and three contiguous stereogenic centers.
© 2020. Springer Nature Switzerland AG.

Entities:  

Keywords:  Diastereoselectivity; Polycyclic Architectures; Quinolinobenzo[a]phenazinone; Solid State Melt Reaction (SSMR); [4+2]-Cycloaddition

Mesh：

Substances：

Year:  2020        PMID： 32367313     DOI： 10.1007/s11030-020-10090-6

Source DB:  PubMed          Journal:  Mol Divers        ISSN： 1381-1991            Impact factor:   2.943


  36 in total

1.  Potent quinoxaline-based inhibitors of PDGF receptor tyrosine kinase activity. Part 2: the synthesis and biological activities of RPR127963 an orally bioavailable inhibitor.

Authors:  Wei He; Michael R Myers; Barbara Hanney; Alfred P Spada; Glenda Bilder; Helen Galzcinski; Dilip Amin; Saul Needle; Ken Page; Zaid Jayyosi; Mark H Perrone
Journal:  Bioorg Med Chem Lett       Date:  2003-09-15       Impact factor: 2.823

2.  Arylglyoxals in synthesis of heterocyclic compounds.

Authors:  Bagher Eftekhari-Sis; Maryam Zirak; Ali Akbari
Journal:  Chem Rev       Date:  2013-01-25       Impact factor: 60.622

3.  Elucidation of fatty acid amide hydrolase inhibition by potent alpha-ketoheterocycle derivatives from Monte Carlo simulations.

Authors:  Cristiano Ruch Werneck Guimarães; Dale L Boger; William L Jorgensen
Journal:  J Am Chem Soc       Date:  2005-12-14       Impact factor: 15.419

4.  Regioselective synthesis of polysubstituted pyrazoles and isoxazoles.

Authors:  A R Katritzky; M Wang; S Zhang; M V Voronkov; P J Steel
Journal:  J Org Chem       Date:  2001-10-05       Impact factor: 4.354

5.  Natural product inspired diversity oriented synthesis of tetrahydroquinoline scaffolds as antitubercular agent.

Authors:  Atul Kumar; Suman Srivastava; Garima Gupta; Vinita Chaturvedi; Sudhir Sinha; R Srivastava
Journal:  ACS Comb Sci       Date:  2010-11-10       Impact factor: 3.784

6.  Quinazolin-4-one derivatives from Streptomyces isolates.

Authors:  Rajendra P Maskey; Mohamed Shaaban; Iris Grün-Wollny; Hartmut Laatsch
Journal:  J Nat Prod       Date:  2004-07       Impact factor: 4.050

7.  A Novel Synthesis of 1,3,5-Trisubstituted Pyrazoles through a Spiro-pyrazoline Intermediate via a Tandem 1,3-Dipolar Cycloaddition/Elimination.

Authors:  Sureshbabu Dadiboyena; Edward J Valente; Ashton T Hamme
Journal:  Tetrahedron Lett       Date:  2009-01-21       Impact factor: 2.415

8.  Tetrazolo[1,5-a]quinoline as a potential promising new scaffold for the synthesis of novel anti-inflammatory and antibacterial agents.

Authors:  Adnan A Bekhit; Ola A El-Sayed; Elsayed Aboulmagd; Ji Young Park
Journal:  Eur J Med Chem       Date:  2004-03       Impact factor: 6.514

9.  Synthesis of fully substituted pyrazoles via regio- and chemoselective metalations.

Authors:  Christina Despotopoulou; Lydia Klier; Paul Knochel
Journal:  Org Lett       Date:  2009-08-06       Impact factor: 6.005

10.  Synthesis of ethyl 3-aryl-1-methyl-8-oxo- 8H-anthra[9,1-gh]quinoline-2-carboxylates as dyes for potential application in liquid crystal displays.

Authors:  Vladimir B Bojinov; Ivo K Grabchev
Journal:  Org Lett       Date:  2003-06-12       Impact factor: 6.005
View more
  2 in total

Review 1.  A review on lawsone-based benzo[a]phenazin-5-ol: synthetic approaches and reactions.

Authors:  Abolfazl Olyaei; Mahdieh Sadeghpour
Journal:  RSC Adv       Date:  2022-05-09       Impact factor: 4.036

2.  Synthesis of (E)-2-(1H-tetrazole-5-yl)-3-phenylacrylenenitrile derivatives catalyzed by new ZnO nanoparticles embedded in a thermally stable magnetic periodic mesoporous organosilica under green conditions.

Authors:  Sajedeh Safapoor; Mohammad G Dekamin; Arezoo Akbari; M Reza Naimi-Jamal
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.